Forecast: NCI UM1 funding for ETCTN Lead Academic Organizations to run early-phase cancer trials
NCI plans to release a UM1 NOFO in Summer 2025 to fund Lead Academic Organizations for the Experimental Therapeutics Clinical Trials Network. Awardees will design and oversee early-phase cancer trials using NCI-sponsored IND agents, mentor early-stage investigators, and use the network’s central pharmacokinetics lab. Applications are not yet being accepted; the anticipated due date is Fall 202…
The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications from institutions/organizations that propose to maintain or establish Lead Academic Organizations (LAOs) as part of the NCI Experimental Therapeutics Clinical Trials Network (ETC…
Funding Source
Awards & funding
Eligibility
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers